Controlled substances
Novel Technique Improves Analysis of Thermally Unstable Illicit Drugs
Prescription Drug Monitoring Program: Registration and Use by Prescribers and Pharmacists Before and After Legal Mandatory Registration, California
Video: Advances in Investigative Techniques: Drug Monitoring Programs
Recent Advances in Comprehensive Chromatographic Analysis of Emerging Drugs
Video: Advances in Investigative Techniques: Drug Monitoring Programs
Law Enforcement Officers' Perceptions of Florida's Prescription Drug Monitoring Program
Office of Justice Programs (OJP) / Centers for Disease Control and Prevention (CDC) Federal Medicolegal Death Investigation Interagency Working Group (MDI-IWG) Resource Page
The Department of Justice’s (DOJ) Office of Justice Programs (OJP) and the U.S. Health and Human Services’ (HHS) Center for Disease Control and Prevention (CDC) established this Federal Medicolegal Death Investigation (MDI) Interagency Working Group (MDI-IWG) to coordinate Federal initiatives to strengthen MDI systems and support death investigation services practiced by medical examiner and coroner offices (MECs) across the United States. The MDI-IWG commenced in...
Fatal Poisonings Involving Propoxyphene Before and After Voluntary Withdrawal From the United States Market: An Analysis From the State of Florida
Law Enforcement Resources
OJP, along with DOJ partners, are committed to supporting and protecting America's law enforcement. Featured resources include officer safety & wellness, DOJ resources, VALOR, tribal law enforcement, and helping law enforcement combat opioids.